tiprankstipranks
Trending News
More News >
Endo Manufacturing Co., Ltd. (JP:7841)
:7841
Japanese Market
Advertisement

Endo Manufacturing Co., Ltd. (7841) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7841

Endo Manufacturing Co., Ltd.

(7841)

Rating:81Outperform
Price Target:
¥1,275.00
▲(4.51% Upside)
Endo Manufacturing Co., Ltd. achieves a strong overall stock score, driven by robust financial performance and reasonable valuation. The technical analysis supports a positive short-term outlook, though longer-term trends suggest caution. The absence of earnings call insights and corporate events did not impact the score.

Endo Manufacturing Co., Ltd. (7841) vs. iShares MSCI Japan ETF (EWJ)

Endo Manufacturing Co., Ltd. Business Overview & Revenue Model

Company DescriptionEndo Manufacturing Co., Ltd. (7841) is a Japanese company primarily engaged in the manufacturing and sale of industrial equipment and machinery. The company specializes in producing a range of products including but not limited to hoists, cranes, and other material handling equipment. With a focus on quality and innovation, Endo Manufacturing serves various industries, ensuring reliable and efficient solutions for material transportation and handling needs.
How the Company Makes MoneyEndo Manufacturing Co., Ltd. generates revenue through the sale of its industrial equipment and machinery. The company's primary revenue stream comes from the manufacturing and distribution of hoists, cranes, and material handling systems, which are essential for industries requiring heavy lifting and transportation solutions. Additionally, Endo Manufacturing may engage in maintenance services and after-sales support, providing ongoing value to customers and generating repeat business. The company may also benefit from strategic partnerships or collaborations with other industrial firms, enhancing its market reach and customer base.

Endo Manufacturing Co., Ltd. Financial Statement Overview

Summary
Endo Manufacturing Co., Ltd. demonstrates robust financial health with strong revenue growth and solid profit margins. The balance sheet is stable with low leverage, but there are minor challenges in gross profit and operating cash flow trends.
Income Statement
85
Very Positive
Endo Manufacturing Co., Ltd. has shown strong revenue growth with a consistent upward trajectory from 2020 to 2024, notably a 10.88% increase from 2023 to 2024. The gross profit margin has remained healthy, and the net profit margin has improved significantly to 6.42% in 2024 from 4.86% in 2023. Both EBIT and EBITDA margins are robust, indicating efficient operations. However, the dip in gross profit in 2024 suggests some cost management challenges.
Balance Sheet
88
Very Positive
The company exhibits a strong balance sheet with a high equity ratio of 83.86% in 2024, reflecting financial stability and low reliance on debt. The debt-to-equity ratio is impressively low at 0.0079, minimizing financial risk. Return on equity has improved to 5.03%, indicating better utilization of equity to generate profits, though it could be higher for optimal performance.
Cash Flow
78
Positive
Endo Manufacturing's cash flow management is sound, with positive free cash flow indicating efficient capital expenditure control. However, the operating cash flow has decreased in 2024 compared to 2023, which may indicate rising operational costs or reduced cash conversion efficiency. The free cash flow to net income ratio remains positive, underscoring strong cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue17.68B17.42B15.71B14.58B12.59B8.28B
Gross Profit3.34B3.48B2.76B3.73B3.56B1.45B
EBITDA2.63B2.72B2.16B2.82B2.74B979.74M
Net Income900.23M1.12B762.90M796.80M1.60B-88.10M
Balance Sheet
Total Assets26.34B26.48B24.02B21.87B20.48B17.96B
Cash, Cash Equivalents and Short-Term Investments8.83B9.86B9.04B7.26B6.83B6.44B
Total Debt503.85M175.00M275.00M375.00M1.07B700.00M
Total Liabilities4.90B4.28B4.05B3.50B3.74B2.72B
Stockholders Equity21.44B22.20B19.97B18.37B16.73B15.24B
Cash Flow
Free Cash Flow0.00354.93M1.58B889.84M709.06M-73.95M
Operating Cash Flow0.001.76B2.40B1.93B1.58B599.62M
Investing Cash Flow0.00-1.31B-606.68M-1.03B-1.41B-828.27M
Financing Cash Flow0.00-287.29M-298.36M-868.55M231.35M-260.00M

Endo Manufacturing Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1220.00
Price Trends
50DMA
1150.40
Positive
100DMA
1144.84
Positive
200DMA
1205.43
Positive
Market Momentum
MACD
12.72
Positive
RSI
56.32
Neutral
STOCH
34.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7841, the sentiment is Positive. The current price of 1220 is below the 20-day moving average (MA) of 1221.10, above the 50-day MA of 1150.40, and above the 200-day MA of 1205.43, indicating a neutral trend. The MACD of 12.72 indicates Positive momentum. The RSI at 56.32 is Neutral, neither overbought nor oversold. The STOCH value of 34.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7841.

Endo Manufacturing Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥10.44B11.08
3.28%9.78%-7.79%
80
Outperform
¥8.77B3.08
4.02%7.24%216.11%
61
Neutral
$17.99B12.87-3.58%2.97%1.27%-14.28%
¥9.25B9.50
2.38%
78
Outperform
¥4.23B16.48
4.59%10.09%-3.61%
73
Outperform
¥14.06B12.27
2.44%0.75%-1.86%
¥2.04B29.42
8.87%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7841
Endo Manufacturing Co., Ltd.
1,220.00
32.12
2.70%
JP:7608
SK Japan Co., Ltd.
1,135.00
434.50
62.03%
JP:7809
KOTOBUKIYA CO., LTD.
1,679.00
67.14
4.17%
JP:7847
Graphite Design Inc.
654.00
-49.88
-7.09%
JP:7865
People Co., Ltd.
533.00
-173.00
-24.50%
JP:8135
ZETT CORP.
448.00
130.27
41.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 19, 2025